Effects of A-423579, a novel histamine-3 receptor antagonist in rodent models of diet-induced obesity

被引：0
|
作者：
Fey, TA [1 ]
Bush, EN [1 ]
Dickinson, RW [1 ]
Shapiro, R [1 ]
Knourek-Segel, VE [1 ]
Droz, BA [1 ]
McDowell, CA [1 ]
Jacobson, PB [1 ]
Faghih, R [1 ]
Hancock, AA [1 ]
Brune, ME [1 ]
机构：
[1] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
FASEB JOURNAL | 2004年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A574 / A574
页数：1
相关论文
共 50 条
  • [31] The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance
    Jbilo, O
    Ravinet-Trillou, C
    Arnone, M
    Buisson, I
    Bribes, E
    Péleraux, A
    Pénarier, G
    Soubrié, P
    Le Fur, G
    Galiègue, S
    Casellas, P
    FASEB JOURNAL, 2005, 19 (09): : 1567 - +
  • [32] Gastric inhibitory polypeptide receptor antagonist, SKL-14959, suppressed body weight gain on diet-induced obesity mice
    Nakamura, T.
    Tanimoto, H.
    Mizuno, Y.
    Okamoto, M.
    Takeuchi, M.
    Tsubamoto, Y.
    Noda, H.
    OBESITY SCIENCE & PRACTICE, 2018, 4 (02): : 194 - 203
  • [33] Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
    Trillou, CR
    Arnone, M
    Delgorge, C
    Gonalons, N
    Keane, P
    Maffrand, JP
    Soubrié, P
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2003, 284 (02) : R345 - R353
  • [34] Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice
    Hildebrandt, AL
    Kelly-Sullivan, DM
    Black, SC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 462 (1-3) : 125 - 132
  • [35] Histamine H3 receptor antagonist ABBOTT-331440 normalizes body weight in male C57BL/6J mice with high fat diet-induced obesity
    Bush, EN
    Shapiro, R
    Nuss, M
    Knourek-Segel, V
    Wilcox, D
    Droz, B
    Faghih, R
    Bennani, Y
    Esbenshade, T
    Jacobson, PB
    Hancock, A
    DIABETES, 2002, 51 : A418 - A418
  • [36] The Effects of Novel Co-Amorphous Naringenin and Fisetin Compounds on a Diet-Induced Obesity Murine Model
    Vasquez-Reyes, Sarai
    Bernal-Gamez, Miranda
    Dominguez-Chavez, Jorge
    Mondragon-Vasquez, Karina
    Sanchez-Tapia, Monica
    Ordaz, Guillermo
    Granados-Portillo, Omar
    Coutino-Hernandez, Diana
    Barrera-Gomez, Paulina
    Torres, Nimbe
    Tovar, Armando R.
    NUTRIENTS, 2024, 16 (24)
  • [37] Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis
    Daniels, Samuel J.
    Leeming, Diana J.
    Detlefsen, Sonke
    Bruun, Maria F.
    Hjuler, Sara T.
    Henriksen, Kim
    Hein, Peter
    Krag, Aleksander
    Karsdal, Morten A.
    Nielsen, Mette Juul
    Brockbank, Sarah
    Cruwys, Simon
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2020, 318 (03): : G410 - G418
  • [38] An insurmountable NPY Y5 receptor antagonist exhibits superior anti-obesity effects in high-fat diet-induced obese mice
    Fukasaka, Yumiko
    Nambu, Hirohide
    Tanioka, Hideki
    Obata, Atsushi
    Tonomura, Misato
    Okuno, Takayuki
    Yukioka, Hideo
    NEUROPEPTIDES, 2018, 70 : 55 - 63
  • [39] Anti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-induced obese mice
    A N A Verty
    S H Lockie
    A Stefanidis
    B J Oldfield
    International Journal of Obesity, 2013, 37 : 279 - 287
  • [40] Anti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-induced obese mice
    Verty, A. N. A.
    Lockie, S. H.
    Stefanidis, A.
    Oldfield, B. J.
    INTERNATIONAL JOURNAL OF OBESITY, 2013, 37 (02) : 279 - 287
12345